-+ 0.00%
-+ 0.00%
-+ 0.00%

EMA'S CHMP: RECOMMENDED TO REFUSE EXTENDING MARKETING AUTHORISATION FOR PEMAZYRE (PEMIGATINIB)

Reuters·03/28/2025 10:47:30

Please log in to view news